MoneyWorks4Me

Shree Ganesh Bio-Tech (India) informs about quarterly statement of investor complaints

06 Jul 2017 Evaluate

In compliance with Regulation 13 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Shree Ganesh Bio-Tech (India) has informed about quarterly statement of Investor Complaints as per Regulation 13 (3) Of SEBI (LODR) Regulation, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers